Clinical Trials · NCT00359762
Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 1,029
- Start date
- Sep 2006
- Locations
- 114 sites, 14 countries
- Primary endpoint
- Number of Patients With Treatment Failure